Related Experiment Video
Updated: Mar 6, 2026
Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Percutaneous left atrial appendage occlusion: New perspectives for the method
Iwona Gorczyca-Michta1, Beata Wożakowska-Kapłon
11st Clinic of Cardiology and Electrotherapy, Swietokrzyskie Cardiology Center, Kielce, Poland. iwona.gorczyca@interia.pl.
Insights
Left atrial appendage occlusion offers an alternative stroke prevention method for atrial fibrillation patients unsuitable for oral anticoagulants. Achieving complete closure remains challenging due to anatomical variations, requiring further research on patient selection and post-procedure care.
Area of Science:
- Cardiology
- Interventional Cardiology
- Medical Devices
Background:
- Ischemic stroke is a significant risk for patients with atrial fibrillation (AF).
- Oral anticoagulants are standard stroke prevention but have contraindications.
- The left atrial appendage is a primary source of thrombi in AF patients.
Purpose of the Study:
- To evaluate percutaneous left atrial appendage occlusion (LAAO) as a stroke prevention strategy.
- To discuss the efficacy and safety of LAAO devices in high-risk AF patients.
- To identify unresolved issues in LAAO therapy.
Main Methods:
- Review of studies investigating percutaneous left atrial appendage occlusion devices since 2002.
- Analysis of safety and efficacy data for various LAAO closure devices.
- Examination of challenges related to variable left atrial appendage anatomy.
Main Results:
- Percutaneous LAAO is a viable option for selected high-risk AF patients.
- Complete closure of the left atrial appendage can be difficult due to anatomical variability.
- Multiple LAAO devices have been developed and studied for safety and efficacy.
Conclusions:
- LAAO is an important therapeutic option for stroke prevention in AF patients with contraindications to anticoagulation.
- Further research is needed on optimal patient selection for LAAO.
- Unresolved issues include complication risks and post-LAAO anticoagulant strategies.
Abstract:
Ischemic stroke is a common complication of atrial fibrillation (AF). Currently, oral anticoagulant drugs are the most commonly used method of stroke prevention. Left atrial appendage occlusion is thought to be the main source of thrombi in patients with AF. Percutaneous left atrial appendage is a valuable therapeutic option for selected high-risk patients with AF and contraindications for oral anticoagulation therapy. While complete closure of the left atrial appendage is the goal of a device implantation the variable nature of the left atrial appendage anatomy makes this goal difficult to achieve. Currently, there are several types of devices available for left atrial appendage occlusion. Since the first percutaneous left atrial appendage occlusion in 2002 many studies have investigated both the safety and efficacy of this therapy using different closure devices. Still unresolved issues include a lack of data on optimal patient selection, risk of complications, and anticoagulant treatment after left atrial appendage occlusion.
